These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 36142676)

  • 1. Novel Roles of RNA m6A Methylation Regulators in the Occurrence of Alzheimer's Disease and the Subtype Classification.
    Li M; Cheng W; Zhang L; Zhou C; Peng X; Yu S; Zhang W
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of m6A RNA methylation regulators with features of immune dysregulation in IgA nephropathy.
    Wang Y; Sun N; He R; Wang Z; Jin J; Gao T; Qu J
    Clin Exp Med; 2024 May; 24(1):92. PubMed ID: 38693353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological characterization and diagnostic models of RNA N6-methyladenosine regulators in Alzheimer's disease.
    Hui Y; Ma Q; Zhou XR; Wang H; Dong JH; Gao LN; Zhang T; Li YY; Gong T
    Sci Rep; 2023 Sep; 13(1):14588. PubMed ID: 37666846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormality of m6A mRNA Methylation Is Involved in Alzheimer's Disease.
    Han M; Liu Z; Xu Y; Liu X; Wang D; Li F; Wang Y; Bi J
    Front Neurosci; 2020; 14():98. PubMed ID: 32184705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Landscape of m6A Regulators in Multiple Brain Regions of Alzheimer's Disease.
    Liu Z; Xia Q; Zhao X; Zheng F; Xiao J; Ge F; Wang D; Gao X
    Mol Neurobiol; 2023 Sep; 60(9):5184-5198. PubMed ID: 37273154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS).
    Zhou S; Hua R; Quan S
    J Ovarian Res; 2023 Apr; 16(1):73. PubMed ID: 37046273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine (m6A) modification and its clinical relevance in cognitive dysfunctions.
    Du B; Zhang Y; Liang M; Du Z; Li H; Fan C; Zhang H; Jiang Y; Bi X
    Aging (Albany NY); 2021 Aug; 13(16):20716-20737. PubMed ID: 34461609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m6A Regulator-Mediated Methylation Modification Patterns and Characteristics in COVID-19 Patients.
    Qing X; Chen Q; Wang K
    Front Public Health; 2022; 10():914193. PubMed ID: 35655464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
    Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
    Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m6A RNA methylation regulators could contribute to the occurrence of chronic obstructive pulmonary disease.
    Huang X; Lv D; Yang X; Li M; Zhang H
    J Cell Mol Med; 2020 Nov; 24(21):12706-12715. PubMed ID: 32961012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of N6-methyladenosine modification during Alzheimer's disease development.
    Gao S; Wang Y; Li X; Liang Y; Jin Z; Yang B; Yuan TF; Tian H; Peng B; Rao Y
    Heliyon; 2024 Mar; 10(6):e26911. PubMed ID: 38496847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer.
    Zhang C; Liu J; Guo H; Hong D; Ji J; Zhang Q; Guan Q; Ren Q
    Bioengineered; 2021 Dec; 12(1):3159-3176. PubMed ID: 34187307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of RNA N6-methyladenosine regulators in the diagnosis and subtype classification of coronary heart disease using the Gene Expression Omnibus database.
    Jiang Y; Pan Y; Long T; Qi J; Liu J; Zhang M
    Front Cardiovasc Med; 2023; 10():1185873. PubMed ID: 37928762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biological significance of RNA N6-methyladenosine regulators in Alzheimer disease.
    Qiu Z; Bai X; Han X; Wang P; Wang X; Lv Y; An Y
    Medicine (Baltimore); 2023 Feb; 102(7):e32945. PubMed ID: 36800593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Landscape analysis of m6A modification regulators related biological functions and immune characteristics in myasthenia gravis.
    Li S; Liu H; Ruan Z; Guo R; Sun C; Tang Y; Huang X; Gao T; Hao S; Li H; Song N; Su Y; Ning F; Li Z; Chang T
    J Transl Med; 2023 Mar; 21(1):166. PubMed ID: 36864526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis.
    Bai Q; Shi M; Sun X; Lou Q; Peng H; Qu Z; Fan J; Dai L
    Front Endocrinol (Lausanne); 2022; 13():957742. PubMed ID: 36034449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
    Qi LW; Jia JH; Jiang CH; Hu JM
    Front Genet; 2020; 11():614566. PubMed ID: 33519919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
    Chen M; Nie ZY; Wen XH; Gao YH; Cao H; Zhang SF
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31808521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer's disease.
    Ni P; Pan K; Zhao B
    PLoS One; 2023; 18(8):e0289068. PubMed ID: 37549144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.